Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Genetic Alterations in Intramedullary Spinal Cord Tumors	The Johns Hopkins University School of Medicine / George Jallo, MD	Innovation Grants	2013	Maryland
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements	University of Cincinnati College of Medicine / Jianjun Chen, PhD	Innovation Grants	2013	Ohio
Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies	Baylor College of Medicine / Stephen Gottschalk, MD	Innovation Grants	2013	Texas
Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG)	Baylor College of Medicine / Nabil Ahmed, MD, MSc	Innovation Grants	2013	Texas
An Intersection of Cell Metabolism and Differentiation in Childhood Sarcomas	Cedars-Sinai Medical Center / Sandra Orsulic, PhD	Innovation Grants	2013	California
Novel Targeted Therapies for Rhabdomyosarcoma	St. Jude Children’s Research Hospital / Michael Dyer, PhD	Innovation Grants	2013	Tennessee
Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias	University of California at Santa Cruz / Camilla Forsberg, PhD	Innovation Grants	2013	California
Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma	Duke University / Corinne Mary Linardic, MD, PhD	Innovation Grants	2013	North Carolina
Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma	Columbia University Medical Center / Darrell Yamashiro, MD, PhD	Innovation Grants	2013	New York
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1	Dana-Farber Cancer Institute / Loren Walensky, MD, PhD	Innovation Grants	2013	Massachusetts

Pages